ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Avacta

Avacta (AVCT)

48,00
1,00
(2,13%)
Geschlossen 03 Dezember 5:30PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
48,00
Gebot
47,00
Fragen
49,00
Volumen
1.241.327
47,00 Tagesbereich 49,50
39,75 52-Wochen-Bereich 139,00
Marktkapitalisierung
Handelsende
47,00
Handelsbeginn
47,00
Letzte Trade
30000
@
48
(O)
Letzter Handelszeitpunkt
Finanzvolumen
602.044p
VWAP
48,50
Durchschnittliches Volumen (3 Mio.)
2.152.257
Ausgegebene Aktien
359.042.104
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-6,91
Gewinn pro Aktie (EPS)
-0,07
Erlöse
23,25M
Nettogewinn
-24,95M

Über Avacta

Sektor
Pharmaceutical Preparations
Branche
Food Processors Div'd
Website
Hauptsitz
Wetherby, Gbr
Gegründet
2003
Avacta is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker AVCT. The last closing price for Avacta was 47,00p. Over the last year, Avacta shares have traded in a share price range of 39,75p to 139,00p.

Avacta currently has 359.042.104 shares in issue. The market capitalisation of Avacta is £168,75 million. Avacta has a price to earnings ratio (PE ratio) of -6.91.

AVCT Neueste Nachrichten

Avacta Group PLC R&D Spotlight focusing on pipeline advances

Avacta Group PLC 30 October 2024   Avacta Group plc   ("Avacta" or "the Group" or "the Company")   R&D Spotlight focusing on pre|CISION® technology and pipeline advances   LONDON - Oct...

Avacta Group PLC Block Listing Six Monthly Return

Avacta Group PLC 28 October 2024               28 October 2024   Avacta Group plc   ("Avacta" or "the Group" or "the Company")   Block Listing Six Monthly Return     Avacta Group plc (AIM:...

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona LONDON – Oct...

Avacta Group PLC Avacta Reports Pipeline Avances at EORTC

Avacta Group PLC 24 October 2024       Avacta Group plc   ("Avacta" or "the Group" or "the Company")   Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular...

Avacta Group PLC Issue of Equity and Total Voting Rights

Avacta Group PLC 21 October 2024   Avacta Group plc   ("Avacta" or the "Group" or the "Company")   Issue of Equity and Total Voting Rights   London - Oct. 21, 2024 - Avacta Therapeutics (AIM:...

Avacta partners with Tempus to enable AI-driven drug development

Avacta Group PLC on Monday revealed it has agreed to collaborate with AI-focused precision medicine business, Tempus ...

Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology LONDON – Oct. 21, 2024 – Avacta...

Avacta Group PLC Avacta and Tempus Enter Strategic Collaboration

Avacta Group PLC 21 October 2024       Avacta Group plc   ("Avacta" or "the Group" or "the Company")   Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in...

Avacta expands pipeline with two novel preclinical assets

Avacta Group PLC on Thursday revealed it has expanded its oncology pipeline with two novel preclinical assets. AVA6 ...

Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform

Avacta Group plc ("Avacta" or "the Group" or "the Company")Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform London, Oct. 17, 2024 – Avacta Group plc...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-2-4505045.5110217847.44373719DE
4-4-7.692307692315253.542.75170038947.97083349DE
12-22-31.42857142867077.542215225754.77026081DE
265.2512.280701754442.758639.75215369659.10300741DE
52-87-64.444444444413513939.75234072462.91633322DE
156-68-58.6206896552116187.538.5193989292.5527684DE
26031.5190.90909090916.529013.52639652115.5209878DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SCGLSealand Capital Galaxy Limited
0,54p
(80,00%)
30,47M
OBDOxford Biodynamics Plc
2,11p
(55,15%)
8,03M
MIRIMirriad Advertising Plc
0,18p
(33,33%)
23,04M
CLCOCloudcoco Group Plc
0,26p
(30,00%)
3,42M
IESInvinity Energy Systems Plc
15,00p
(27,66%)
4,57M
ZNTZentra Group Plc
3,50p
(-36,36%)
221,85k
UOGUnited Oil & Gas Plc
0,125p
(-34,21%)
123,45M
SYSSysgroup Plc
21,50p
(-24,56%)
788,98k
ADAAdams Plc
3,50p
(-22,22%)
25k
DSMDowning Strategic Micro-cap Investment Trust Plc
3,70p
(-21,28%)
22,32k
ORCPOracle Power Plc
0,0525p
(-7,89%)
3,63B
NTVONativo Resources Plc
0,0023p
(-8,00%)
1,51B
SYMESupply@me Capital Plc
0,0031p
(-10,14%)
1,11B
KEFIKefi Gold And Copper Plc
0,524p
(-19,63%)
561,97M
ENETEthernity Networks Ltd
0,1425p
(18,75%)
547,92M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen